跳至主要内容
临床试验/IRCT20211127053190N1
IRCT20211127053190N1招募中2 期

Comparative evaluation of cardiovascular effects of 0.5% Ropivacaine front 2% Lidocaine with 1:80000 epinephrine in implant surgery, A double-blind crossover clinical trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 18 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 70 years(—)
性别
All

入选标准

  • Patients who need to place 1 implant bilaterally in the posterior areas (premolar or molar) in one jaw
  • Systemically healthy individuals (ASA I)

排除标准

  • Patients with a history of allergy to local anesthetic agents, amides and sulfides
  • Patients with acute or chronic infection near the surgical site
  • Alcohol consumption
  • Consumers of antipsychotic drugs, antidepressants and oral contraceptives
  • People who have taken painkillers in the 48 hours before surgery
  • People with a history of chronic facial pain
  • Pregnant and lactating women
  • Patients who need immediate implant placement (class1)
  • Patients who need open / closed sinus lift surgery at the surgical site
  • Patients who need bone augmentation (GBR) at the surgical site
  • Patients who refuse to take part in the research

研究者

相似试验